全球免疫细胞治疗药物开发现状与趋势

目的:从产品开发角度分析免疫细胞治疗类药物的发展现状和未来趋势。方法:检索科睿唯安(Clarivate Analytics)的Cortellis数据库的数据,利用定量分析法和对比分析法对检索结果进行分析。结果:目前已有2种免疫细胞治疗类药物上市,1种免疫细胞治疗类药物处于预注册阶段,4种药物处于临床Ⅲ期,同时大量处于临床Ⅱ/Ⅰ期药物显示未来市场上将有更多免疫细胞治疗类药物。产品交易方面,目前在免疫细胞治疗类药物的商业交易也趋向频繁。通过列举分析目前已发生的交易金额前十的交易,发现其中药物开发及商业化许可是最主要的交易模式。结论:目前免疫细胞治疗类药物市场尚处于起步阶段,但随着未来技术的不断发展改进,相信未来有更多的药物进入商用市场,为癌症及其他疾病的治疗提供新的契机。

Development Status and Trend Analysis of Immune System Cell Therapies

Objective: To analyze the development status and trend of immune system cell therapies in the sense of product manufacturing.Methods: Based on the Cortellis database of clarivate analytics,this paper analyzed the searching results with utilizing both quantitative and comparative analysis methods. Results: Currently,two immune system cell therapy drugs have been launched into markets,another one drug is at Pre-registration phase and four are at phase Ⅲ clinical trial phase. In addition, business deals related to immune system cell therapies are increasing in recent years. This paper analyzed the Top 10 valued deals related to immune system cell therapy drugs,indicating that the main agreement type was the drug development,commercial license.Conclusion: Although immune system cell therapy market still at its preliminary stage,with continuous development and improvement of future technologies,more drugs will be launched in the future,providing new options for the treatment of cancer and other diseases.